AFGGX
Price
$23.90
Change
-$0.19 (-0.79%)
Updated
Jul 10 closing price
Net Assets
125.07M
RSLCX
Price
$77.31
Change
-$0.07 (-0.09%)
Updated
Jul 10 closing price
Net Assets
94.26B
Interact to see
Advertisement

AFGGX vs RSLCX

AFGGX vs RSLCX Comparison Chart in %
View a ticker or compare two or three
VS
AFGGX vs. RSLCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFGGX is a StrongBuy and RSLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 94.3B vs. AFGGX (125M). RSLCX pays higher dividends than AFGGX: RSLCX (0.42) vs AFGGX (0.00). AFGGX was incepted earlier than RSLCX: AFGGX (22 years) vs RSLCX (24 years). RSLCX (1.30) and AFGGX (1.28) have similar cost to investors . RSLCX is a more actively managed with annual turnover of: 41.00 vs. AFGGX (38.00). RSLCX has a lower initial minimum investment than AFGGX: RSLCX (250) vs AFGGX (1000). AFGGX annual gain was more profitable for investors over the last year : 26.66 vs. RSLCX (13.15). AFGGX return over 5 years is better than : 18.44 vs. RSLCX (-6.20).
AFGGXRSLCXAFGGX / RSLCX
Total Expense Ratio1.261.3097%
Annual Report Gross Expense Ratio1.281.3098%
Fund Existence22 years24 years-
Gain YTD17.79211.854150%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets125M94.3B0%
Annual Yield % from dividends0.000.42-
Returns for 1 year26.6613.15203%
Returns for 3 years47.9428.56168%
Returns for 5 years18.44-6.20-297%
Returns for 10 years63.4679.7080%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRIAX2.52N/A
N/A
Franklin Income Adv
GSMYX25.93N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
BDBPX32.05N/A
N/A
iShares Russell 2000 Small-Cap Idx Inv P
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C